ELITech is an in-vitro diagnostic company Hospitals and laboratories in more than 100 countries use ELITech’s products PAI invested in the business in 2017 UPDATED. PAI Partners will hit a 3.7x gross ...

TORINO, Italy--(BUSINESS WIRE)-- Bruker Corporation (Nasdaq: BRKR) announced today that it has entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of PAI ...

Bruker Corporation BRKR recently entered into a definitive share purchase agreement with TecFin S.à r.l., a controlled affiliate of the pre-eminent private equity firm PAI Partners, to acquire ...

ELITech is a differentiated, fast growing and profitable provider of systems and assays for molecular diagnostics (MDx), biomedical systems/specialty IVD, and microbiology ELITech offers the ...

Mirina, the new entity, gained Nanogen’s technology that aims to enhance miRNA drugs. Nanogen and The Elitech Group entered a definitive merger agreement. Separately, Nanogen also created a technology ...

Continuing its aggressive buying spree, Bruker Corp. entered into a definitive share purchase agreement with Tecfin S.à r.l. to acquire molecular diagnostics (MDx) company Elitechgroup SAS for €870 ...

Upon completion of the transaction, ELITech is expected to operate as a stand-alone entity within Bruker’s Microbiology and Infection Diagnostics division. Bruker plans to fund the acquisition with ...

(MENAFN- JCN NewsWire) Entered a partnership with ELITech in the Field of Molecular Testing for Infectious Disease Joint developing and offering fully automated PCR testing system TOKYO, September 25, ...

TORINO, Italy--(BUSINESS WIRE)--Bruker Corporation (Nasdaq: BRKR) is pleased to announce the closing of its acquisition of ELITechGroup ("ELITech") for €870 million in cash, excluding the carved out ...